Multi‐lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation
Biotechnology and Bioengineering · 2024
DOI: 10.1002/bit.28563 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2024. Written by Linus Weiß and 5 co-authors. Institution: Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. Major MEDLINE topics: MicroRNAs. Cited 15 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
A large number of companies observe polysorbate (PS) degradation and associated (sub‐)visible particle formation in biological drug formulations, which compromise the stability of the drug product, ultimately posing a risk toward delivering innovative medicines to patients. The main culprits of PS degradation are hydrolytic host cell proteins (HCPs) originating from the production cell lines, which are mostly Chinese hamster ovary (CHO) cell derived. Here, a small portion of particularly difficult‐to‐remove HCPs—mainly lipases—cause hydrolytic cleavage of PS resulting in the accumulation of free fatty acid aggregates/particles. One possible mitigation strategy is the removal of such critical HCPs in the production cell line. Multigene regulation can be achieved via microRNAs (miRNAs) thereby serving as a smart tool to reduce the expression of different target genes using a single miRNA. To enable a tailored gene regulation of multiple specific target lipases self‐designed and non‐naturally occurring artificial miRNAs (amiRNA) can be designed. Based on micro‐conserved regions in the mRNA sequence of two sets of target HCPs, we provide a proof‐of‐concept for a simultaneous multi‐lipase knockdown in CHO cells using single amiRNAs. By this, we were not only able to reduce PS degradation but laid the foundation to expand this tool to other areas of cell line phenotype engineering.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
- Early Stage Pharmaceutical Development, Pharmaceutical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
- Late Stage DSP, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
ORCID profiles: Linus Weiß, Simon Fischer
Cite
APA
Weiß, L., Schmieder-Todtenhaupt, V., Haemmerling, F., Lakatos, D., Schulz, P., & Fischer, S. (2024). Multi‐lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28563
Vancouver
Weiß L, Schmieder-Todtenhaupt V, Haemmerling F, Lakatos D, Schulz P, Fischer S. Multi‐lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28563
BibTeX
@article{Wei2024,
author = {Weiß, Linus and Schmieder-Todtenhaupt, Valerie and Haemmerling, Frank and Lakatos, Daniel and Schulz, Patrick and Fischer, Simon},
title = {Multi‐lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation},
journal = {Biotechnology and Bioengineering},
year = {2024},
doi = {10.1002/bit.28563}
}
EUVIMED